Genetic Technologies

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch GENE and buy or sell other stocks, ETFs, and their options commission-free!

About GENE

Genetic Technologies Ltd. engages in the provision of molecular risk assessment for cancer. It operates through the USA and Australia geographical segments. 

CEO
Paul Alexander Kasian
CEOPaul Alexander Kasian
Employees
Employees
Headquarters
Fitzroy, Victoria (VIC)
HeadquartersFitzroy, Victoria (VIC)
Founded
1987
Founded1987
Employees
Employees

GENE Key Statistics

Market cap
13.48M
Market cap13.48M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
105.19K
Average volume105.19K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$1.58
52 Week high$1.58
52 Week low
$0.512
52 Week low$0.512
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.